glp 1 training iFIT The Future of GLP-1 Therapy:

2026 is the year in which the long-term themes, the true drivers of sustainable success for the burgeoning landscape of obesity treatment, prescription medicines and beyond, become apparent

How MNS Can Help Policy changes like this can create added administrative work and delays

Childhood obesity has assumed epidemic proportions

Semaglutide works in the same way as a hormone produced in the gut by increasing the amount of insulin that the pancreas releases in response to food.

doi: 10.1038/s41392-022-01149-x

Stigma surrounding GLP-1 weight loss treatments reveals societal biases, impacting individuals' mental health and the effectiveness of obesity interventions.